EMCR Research Translation Seminar - The Value of Partnerships

 

Professor Emeritus Adrian Bauman AO is Sesquicentenary Professor of Public Health and Director of the Prevention Research Collaboration at the University of Sydney. Prof Bauman is an internationally recognised public health physician, researcher and teacher. He has academic expertise in many aspects of the primary prevention of chronic disease, with an emphasis on physical activity and obesity prevention epidemiology, population-level interventions and policy research. He has a strong interest in research translation and in the evaluation of complex preventive health programs.

Professor Bauman co-directs the WHO Collaborating Centre on Physical Activity, Nutrition and Obesity, and has assisted in the development of national physical activity and NCD prevention policy, plans and surveillance systems in many countries. Current projects are in physical activity epidemiology, population surveillance , evaluating complex public health programs, implementation science/ research translation, and the evaluation of health related social marketing and mass media/social media campaigns. Prof Bauman was appointed Officer of the Order of Australia (AO) in 2021.

A/Prof Hassett is an Associate Professor in Physiotherapy in the Sydney School of Health Sciences, University of Sydney and Senior Research Fellow in the Institute for Musculoskeletal Health, a partnership between the University of Sydney and Sydney Local Health District. A/Prof Hassett leads the Capacity and Capability Stream for the Sydney Health Partners Implementation Science Program and is the incoming chairperson of the FMH Academic Implementation Science Network and outgoing chairperson of the Physiotherapy Evidence Database (PEDro) Education and Training Committee.

A/Prof Hassett conducts research to test the effectiveness of interventions to improve mobility and physical activity in older adults and adults living with disability and to evaluate the implementation of effective interventions into practice. A/Prof Hassett is a previous NHMRC Translating Research into Practice (TRIP) Fellow and currently leads two MRFF grants as CIA and one NHMRC partnership grant as CIB, all supporting implementation studies to implement physical activity promotion within the healthcare system to increase physical activity in older adults and adults living with disability.

Professor Georgina Long AO, BSc (Hons1, UM) PhD MBBS (Hons) FRACP FAHMS is Co-Medical Director of Melanoma Institute Australia (MIA), and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney.

She leads an extensive clinical trials team and laboratory at MIA, with a focus on targeted therapies and immuno-oncology in melanoma. She is principal investigator on phase I, II and III clinical trials in adjuvant and metastatic melanoma, including trials in patients with active brain metastases. She is the chief investigator on NHMRC funded research into the molecular biology of melanoma.

In recognition of her ground-breaking research and work, Professor Long was recognized with the Australian Academy of Health and Medical Sciences Outstanding Female Research Medal 2021 and was appointed as an Officer of the Order of Australia (2020). She is also Clarivate highly-cited Researcher for 2017-2022, and in November 2022 she was ranked the world’s 1st melanoma expert in all fields and discipline.  To read more about Professor Long see the Melanoma Institute Australia website.

Dr Mitchell Sarkies is a Senior Lecturer and NHMRC Emerging Leadership Fellow at the Sydney School of Health Sciences. Dr Sarkies leads the Innovation and Methods Stream for the Sydney Health Partners Implementation Science Program and is a member of the Academic Implementation Science Network, which supports advancements in the science of implementation in health.

Dr Sarkies is a health services researcher and implementation scientist with a clinical background in physiotherapy. Dr Sarkies leads multiple programs of research harnessing implementation science and complexity science to enhance evidence-informed models of care of hip fracture; developing an implementation strategy for improving the detection of familial hypercholesterolaemia; implementing a primary-tertiary shared care model for scaling up genetic medicine; and implementation of evidence and consensus-based perioperative care pathways to reduce unwarranted clinical variation in elective surgery.

Professor Richard Scolyer AO, BMedSci, MBBS, MD, FRCPA, FRCPath, FAHMS is Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; Co- Medical Director, Melanoma Institute Australia; and Conjoint Professor, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney.  He provides a clinical consultation service for the diagnosis of difficult pigmented lesions and receives more than 2000 cases for opinion from Australasia and beyond annually.  Prof Scolyer effectively integrates his clinical practice with leading an award-winning translational melanoma research laboratory.

In June 2021, he was appointed Officer of the Order of Australia (AO) for distinguished service to medicine, particularly in the field of melanoma and skin cancer, and to national and international professional organisations by The Governor-General of the Commonwealth of Australia.  Together with other MIA colleagues, Richard has been chief investigator on 3 consecutive 5 year NHMRC program grants (2006-2021) and has received multiple personal Fellowships from the NHMRC and CINSW.  In November 2022, he was ranked the world’s 6th leading melanoma expert in any field or discipline and the world’s leading melanoma pathologist.  To read more about Professor Scolyer see the Melanoma Institute Australia website.

Professor Cathie Sherrington FAHMS, FACP, PhD, MPH, BAppSc (Physio) is Professor at Sydney School of Public Health, The University of Sydney. Prof Sherrington is Deputy Director, Institute for Musculoskeletal Health, NHMRC Senior Research Fellow, Director of the CRE in Prevention of Falls Injuries and Co-Chair of the Sydney Health Partners Musculoskeletal Clinical Academic Group.

Prof Sherrington’s research focuses on physical activity interventions to prevent falls and enhance mobility in older people and people with physical disabilities. She is leader of the Physical Activity, Ageing and Disability Research Stream within the Institute for Musculoskeletal Health, a partnership between the University and Sydney Local Health District.

Prof Sherrington has authored over 280 journal articles including reports of 47 clinical trials (18 with NHMRC funding) and 26 systematic reviews. The impact of these publications is indicated by publication citation rates (32,7000+ citations), use in at least 127 guidelines from 26 countries (e.g. NICE, WHO). Prof Sherrington is ranked # 3 researcher in the world for ‘independent living/falls’ by Scopus and ‘accidental falls’ by Expertscape. She is a Fellow of the Australian Academy of Health and Medical Sciences and the Australian College of Physiotherapists.

Associate Professor Angela Todd has extensive work experience in health research, research funding, service development, service evaluation, policy development, education and training, and strategic planning. She has worked for government, public hospitals, universities, and non-government organisations both in Australia and Canada. Her research interests include patient-centred care, early child development, and the use of research in health care.

Angela joined Sydney Health Partners in 2016 and is now Research Director. She leads two of SHP’s four priority platforms. Enabling Research focuses on supporting operational processes and structures critical to high quality research such as research governance approval processes, data sharing, consumer involvement in research, and clinical trial activity. She also directs the Optimising Innovation platform which provides seed funding opportunities for new research ideas and targeted support for larger programs of research that address health service priorities.